News

FDA approves Kerendia for heart failure with ejection fraction of 40% or higher
Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...
Daily Jang16h
FDA approves Kerendia for cardiac failure with LVEF ≥40 percent
In a significant move, the U.S. Food and Drug Administration granted approval for Kerendia for patients with heart failure ...
AHA/ASA Journals12h
The Promise and Peril of Learning Algorithms and Predictive Models in Clinical Decision Support: Be Careful What You Train For
The era of predictive modeling enhanced with machine learning and artificial intelligence (AI) to aid clinical ...
The Brighterside of News on MSN8h
Weight-loss drug Tirzepatide significantly slows breast cancer growth, study finds
Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.